Straumann Holding AG banner

Straumann Holding AG
SIX:STMN

Watchlist Manager
Straumann Holding AG Logo
Straumann Holding AG
SIX:STMN
Watchlist
Price: 84.5 CHF -3.32% Market Closed
Market Cap: CHf13.5B

EV/IC

5.1
Current
32%
Cheaper
vs 3-y average of 7.5

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
5.1
=
Enterprise Value
CHf14.3B
/
Invested Capital
CHf2.7B

Enterprise Value to Invested Capital (EV/IC) ratio compares a company`s total enterprise value to the capital invested in its business. It shows how efficiently the company`s market value reflects the funds used to generate returns.

EV/IC
5.1
=
Enterprise Value
CHf14.3B
/
Invested Capital
CHf2.7B

Valuation Scenarios

Straumann Holding AG is trading below its 3-year average

If EV/IC returns to its 3-Year Average (7.5), the stock would be worth CHf124.78 (48% upside from current price).

Statistics
Positive Scenarios
2/4
Maximum Downside
-73%
Maximum Upside
+70%
Average Upside
0%
Scenario EV/IC Value Implied Price Upside/Downside
Current Multiple 5.1 CHf84.5
0%
3-Year Average 7.5 CHf124.78
+48%
5-Year Average 8.6 CHf143.42
+70%
Industry Average 2.9 CHf48.2
-43%
Country Average 1.4 CHf22.75
-73%

Forward EV/IC
Today’s price vs future invested capital

Not enough data available to calculate forward EV/IC

Peer Comparison

All Multiples
EV/IC
P/E
All Countries
Close
Market Cap EV/IC P/E
CH
Straumann Holding AG
SIX:STMN
13.5B CHF 5.1 37.9
US
Intuitive Surgical Inc
NASDAQ:ISRG
162.6B USD 11 56.9
US
Abbott Laboratories
NYSE:ABT
155.4B USD 2.1 24.8
US
Stryker Corp
NYSE:SYK
112.7B USD 2.9 34.7
IE
Medtronic PLC
NYSE:MDT
102.7B USD 1.5 22.3
US
Boston Scientific Corp
NYSE:BSX
83.8B USD 2.3 23.5
US
Edwards Lifesciences Corp
NYSE:EW
48.8B USD 4.9 44.5
DE
Siemens Healthineers AG
XETRA:SHL
39.3B EUR 1.2 18.6
US
IDEXX Laboratories Inc
NASDAQ:IDXX
45.2B USD 14.9 42.7
US
Becton Dickinson and Co
NYSE:BDX
42.5B USD 1.2 24.2
US
Resmed Inc
NYSE:RMD
29.9B USD 4.2 20.1

Market Distribution

Higher than 89% of companies in Switzerland
Percentile
89th
Based on 1 096 companies
89th percentile
5.1
Low
0 — 0.7
Typical Range
0.7 — 2.5
High
2.5 —
Distribution Statistics
Switzerland
Min 0
30th Percentile 0.7
Median 1.4
70th Percentile 2.5
Max 355 030.1

Straumann Holding AG
Glance View

Straumann Holding AG, headquartered in Basel, Switzerland, has carved a niche in the dental industry by consistently positioning itself at the forefront of innovation and quality. Established in 1954, the company originally delved into alloys used in timepieces and measurement instruments, but it soon pivoted towards medical technology beneath the visionary leadership that embraced research and development. Today, Straumann is a formidable player in the sphere of dental implants, prosthetics, and orthodontic solutions. The company is driven by a simple yet impactful mission: to provide dentists and their patients with the tools and treatments necessary to restore smiles and enhance oral health. Through a robust network of subsidiaries and partners worldwide, Straumann's reach extends to more than 100 countries, facilitating both the manufacturing and distribution of its products on a global scale. The engine behind the company’s success is its dedication to innovation, customer focus, and education. By investing heavily in R&D, Straumann develops cutting-edge products that address the evolving needs of patients and dental professionals. The company's revenue streams primarily originate from the sale of dental implants, restorative products, and digital equipment, making it a major player in both the premium and value segments of the market. Beyond its product offerings, Straumann thrives by training dental professionals through its comprehensive educational initiatives, ensuring its clients are well-prepared to deliver the highest standard of care. This synergistic approach not only amplifies customer loyalty but also firmly establishes Straumann as a trusted leader in the industry.

STMN Intrinsic Value
110.4 CHF
Undervaluation 23%
Intrinsic Value
Price CHf84.5
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett